Starting a GLP-1 receptor agonist isn’t a casual decision. These drugs reshape appetite, slow gastric emptying, and change how your pancreas responds to food. The intake conversation matters because a missed detail can turn a useful prescription into an emergency room visit.<\/p>\n
Most prescribing checklists pull from the FDA labels for Wegovy\u00ae, Ozempic\u00ae, Mounjaro\u00ae, and Zepbound\u00ae, plus the 2023 Obesity Society algorithm. The list below covers what reputable telehealth platforms (TrimRx included) ask in their assessment, and what an endocrinologist would ask in person.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
GLP-1 drugs work by mimicking a gut hormone that affects multiple organ systems at once.<\/strong> The label warnings and clinical trial exclusion criteria exist because real people had real complications during testing.<\/p>\n Quick Answer: Personal or family history of medullary thyroid cancer or MEN2 is an absolute contraindication per the FDA boxed warning<\/p>\n The SUSTAIN 6 trial (Marso et al. 2016 NEJM) excluded patients with severe gastroparesis. SURMOUNT-1 (Jastreboff et al. 2022 NEJM) excluded anyone with a history of pancreatitis. These exclusions weren’t arbitrary, they reflected known mechanisms of harm. Your prescriber needs the same information the trial investigators needed.<\/p>\n A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) is a hard contraindication.<\/strong> The FDA boxed warning on all GLP-1 receptor agonists comes from rodent studies showing C-cell tumors at clinical doses.<\/p>\n The human link is unconfirmed but the warning stands. If a parent, sibling, or child had MTC or MEN2, say so. A history of regular thyroid nodules or Hashimoto’s is generally fine, but tell your doctor anyway so they can order a baseline TSH and calcitonin if indicated.<\/p>\n Any prior episode of acute or chronic pancreatitis is a flag your prescriber needs.<\/strong> The pooled SUSTAIN and PIONEER data showed pancreatitis rates of about 0.4 percent on semaglutide versus 0.2 percent on placebo, low but not zero.<\/p>\n People with a single past episode tied to a known reversible cause (gallstones removed, alcohol use stopped) sometimes still qualify after a risk discussion. Recurrent or idiopathic pancreatitis usually rules out GLP-1 therapy. Don’t downplay an old hospital admission, the records will surface eventually.<\/p>\n Active gallstones, prior cholecystitis, or rapid recent weight loss all raise gallbladder risk on GLP-1s.<\/strong> STEP 1 (Wilding et al. 2021 NEJM) reported cholelithiasis in 2.6 percent of semaglutide users versus 1.2 percent on placebo over 68 weeks.<\/p>\n If you’ve had your gallbladder removed, you’re not at risk for stones but may have looser stools as a baseline that GLP-1 gastroparesis can complicate. Mention the surgery date and any ongoing bile acid sequestrant use.<\/p>\n List every prescription, every over-the-counter, every supplement.<\/strong> The key categories your doctor will flag:<\/p>\n Key Takeaway: Pancreatitis history requires extra caution and shared decision making<\/p>\n Eating disorder history is critical.<\/strong> The 2023 AACE guideline recommends caution prescribing GLP-1s to anyone with active or recent bulimia, binge eating disorder, or restrictive eating, since appetite suppression can worsen disordered patterns.<\/p>\n Alcohol use comes up too. Heavy drinking raises pancreatitis risk independently. Bariatric surgery history (sleeve, bypass, band) doesn’t disqualify you, but changes dosing and monitoring. Pregnancy plans within the next 2 to 3 months mean you shouldn’t start; Wegovy’s label says discontinue 2 months before a planned pregnancy.<\/p>\n A baseline panel for most patients includes a complete metabolic panel, HbA1c, lipid panel, and TSH.<\/strong> Some clinicians add lipase if pancreatitis history is borderline, and amylase if symptoms develop.<\/p>\n If you have any kidney involvement, the FLOW trial (Perkovic et al. 2024 NEJM) showed semaglutide cut kidney and CV death by 24 percent in T2D with CKD, so a baseline eGFR and urine albumin-to-creatinine ratio matter. TrimRx’s assessment flags lab gaps and can coordinate with your local lab.<\/p>\n Wegovy’s label includes a warning about suicidal thoughts and behaviors.<\/strong> The FDA reviewed post-market data in 2024 and didn’t find a causal link, but the warning remains. If you have a history of severe depression, suicidality, or are on multiple psychiatric medications, your prescriber will want to know.<\/p>\n Anxiety around food, body image issues, or a recent psychiatric hospitalization aren’t disqualifiers in most cases, but they shape the support plan. A good telehealth or in-person program coordinates with your therapist or psychiatrist when needed.<\/p>\n Write a single-page summary before your visit or assessment quiz.<\/strong> Include: every diagnosis with the year, every surgery with the year, every current medication with dose, every supplement, every drug or food allergy, family history of thyroid cancer or MEN2, pregnancy plans, alcohol intake, and your weight history.<\/p>\n If you’ve tried other weight loss meds (phentermine, topiramate, naltrexone-bupropion, orlistat), note what happened. TrimRx’s free assessment quiz walks through these prompts in order so nothing gets skipped.<\/p>\n Bottom line: Bring a full medication list including supplements, since insulin and sulfonylureas often need dose cuts<\/p>\n No. Most states allow telehealth prescribing for GLP-1s after a virtual evaluation. TrimRx and similar platforms use an asynchronous questionnaire plus a clinician review. A few states require synchronous video; the assessment will route you correctly based on your address.<\/p>\n Yes, your prescriber will ask whether you’re using insurance or paying cash for compounded medication. The clinical screening is the same either way, but the prescription destination differs.<\/p>\n Tell them immediately when you remember. Most telehealth platforms have a message function for exactly this reason. Adding a forgotten diagnosis after starting is far safer than letting it slide.<\/p>\n Usually no, but sulfonylureas and insulin doses often drop the day you start. Your prescriber will give specific instructions. Don’t make changes yourself.<\/p>\n Yes. Metformin pairs well with GLP-1s and is often continued. The combination is in many T2D guidelines as standard care.<\/p>\n The TrimRx assessment quiz takes about 10 minutes. Clinician review typically returns a decision within 24 to 48 hours, faster if labs are already on file.<\/p>\n Family history of medullary thyroid cancer or MEN2. It’s the only absolute contraindication that patients sometimes don’t know they have, and it changes everything.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" Starting a GLP-1 receptor agonist isn’t a casual decision.<\/p>\n","protected":false},"author":11,"featured_media":93412,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"What Should You Tell Your Doctor Before Starting GLP-1?","_yoast_wpseo_metadesc":"Starting a GLP-1 receptor agonist isn't a casual decision. These drugs reshape appetite, slow gastric emptying, and change how your pancreas responds...","_yoast_wpseo_focuskw":"tell doctor before","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[29],"class_list":["post-90769","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1","tag-glp-1"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=90769"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90769\/revisions"}],"predecessor-version":[{"id":91936,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90769\/revisions\/91936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/93412"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=90769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=90769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=90769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Thyroid History Is a Dealbreaker?<\/h2>\n
What About Pancreatitis?<\/h2>\n
What Gallbladder Issues Should You Mention?<\/h2>\n
What Current Medications Need Disclosure?<\/h2>\n
\n
What Lifestyle and History Details Actually Matter?<\/h2>\n
What Labs Will Your Doctor Want?<\/h2>\n
What Mental Health Context Should Come Up?<\/h2>\n
How Should You Prep for the First Appointment?<\/h2>\n
FAQ<\/h2>\n
Do I Have to See a Doctor in Person Before Starting?<\/h3>\n
Will My Insurance Details Come Up?<\/h3>\n
What If I Forget to Mention Something During Intake?<\/h3>\n
Do I Need to Stop Any Medications Before Starting?<\/h3>\n
Can I Start GLP-1 If I’m Already on Metformin?<\/h3>\n
How Long Does the Intake Process Take?<\/h3>\n
What’s the Single Most Important Thing to Disclose?<\/h3>\n